Stryker (SYK) Gross Margin (2009 - 2026)
Stryker (SYK) posted quarterly Gross Margin of 68.27% for Q2 2026, up 448.0% year-over-year from 12.46% in Q2 2025, and up 7.86% on a QoQ basis from 63.29% in Q1 2026.
Stryker (SYK) Gross Margin (2009 - 2026) Analysis & Trends
Stryker has reported Gross Margin for 18 years, with the latest figure at 68.27% in Q2 2026.
- Gross Margin for Q2 2026 came in at 68.27%, up 448.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 64.98% (up 84.0% YoY), and the FY2025 annual result was 63.96%, up 6.0% from the prior year.
- Gross Margin advanced to 68.27% in Q2 2026, from 63.29% in the prior quarter.
- Over five years, Gross Margin peaked at 68.27% in Q2 2026 and troughed at 62.11% in Q3 2022.
- A 5-year average of 63.82% and a median of 63.68% in 2023 frame the typical range for Gross Margin.
- The widest annual swing landed in 2022, when Gross Margin tumbled 257 bps; it then soared 448 bps in 2026.
- A 5-year view of Gross Margin shows it stood at 62.21% in 2022, then rose by 2 bps to 63.68% in 2023, then gained by 2 bps to 64.85% in 2024, then fell by 0 bps to 64.54% in 2025, then rose by 6 bps to 68.27% in 2026.
- Per Business Quant data, the three most recent Gross Margin figures were 68.27% in Q2 2026, 63.29% in Q1 2026, and 64.54% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 45.84% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 70.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 68.27% |
| Mar 31, 2026 | 63.29% |
| Dec 31, 2025 | 64.54% |
| Sep 30, 2025 | 63.60% |
| Jun 30, 2025 | 63.78% |
| Mar 31, 2025 | 63.83% |
| Dec 31, 2024 | 64.85% |
| Sep 30, 2024 | 64.02% |
| Jun 30, 2024 | 63.00% |
| Mar 31, 2024 | 63.57% |
| Dec 31, 2023 | 63.68% |
| Sep 30, 2023 | 64.33% |
| Jun 30, 2023 | 63.67% |
| Mar 31, 2023 | 63.12% |
| Dec 31, 2022 | 62.21% |
| Sep 30, 2022 | 62.11% |
| Jun 30, 2022 | 62.90% |
| Mar 31, 2022 | 63.95% |
| Dec 31, 2021 | 64.77% |
| Sep 30, 2021 | 63.51% |